Itron (ITRI) Receives Sole Upgrade From Stifel Nicolaus

NEW YORK (TheStreet) -- Stifel Nicolaus has upgraded Itron  (ITRI) on Friday, one of the few analyst firms to do so. The firm upgraded shares to "hold" from "sell," noting that the worst news appears to already be factored into the stock. 

A day earlier, JPMorgan, Brean Capital and Canaccord Genuity downgraded the stock following lower-than-expected guidance from the company. 

The company, which makes electrical meters for the energy sector, expects fiscal 2014 earnings between $1.30 and $1.80 a share with sales of $1.825 million to $1.925 billion. Analysts surveyed by Thomson Reuters had predicted earnings of $2.04 a share on $1.91 billion in revenue.

Also See: Itron Receives Downgrades After Disappointing Guidance

TheStreet Ratings team rates ITRON INC as a Hold with a ratings score of C. The team has this to say about their recommendation:

"We rate ITRON INC (ITRI) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity."

More from Markets

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant